Please login (Members) to view content or
(Nonmembers) this article.
No votes yet

Penicillin Allergy Testing: An Outpatient Nurse-Driven Program for Patients With Cancer

Sejal Morjaria
Faye Inumerables
Dhruvkumar Patel
Nina Cohen
Susan Seo
Susan Posthumus
Steven C. Martin
Anna Kaltsas
Shawna Lee
Nicole Boucher
Erica Fischer-Cartlidge
CJON 2021, 25(2), 143-150 DOI: 10.1188/21.CJON.143-150

Background: Penicillin allergy testing (PAT) can decrease the use of unnecessary antibiotics by clarifying who is truly allergic.

Objectives: This article describes the development and implementation of an oncology outpatient nurse-driven PAT program.

Methods: A nurse-driven program, initiated with allergy screening at the first encounter, was designed to identify patients with oncologic diagnoses eligible for PAT. Once verified eligible, patients undergo a three-step testing process (scratch test, intradermal injection, and IV challenge dose) administered by the infusion nurse.

Findings: From November 2018 to December 2019, 82 outpatients with reported penicillin allergies were screened; 90% were eligible for PAT, and 97% of patients tested were negative for penicillin allergy. A significant reduction in aztreonam use among patients admitted for hematopoietic stem cell transplantation was also noted as compared to before PAT was offered.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or